A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy.
第一作者:
Evan E,Gross
第一单位:
The University of Washington School of Medicine, Seattle, WA.
作者:
医学主题词
人类(Humans);癌, 肾细胞(Carcinoma, Renal Cell);回顾性研究(Retrospective Studies);肾肿瘤(Kidney Neoplasms);肾切除术(Nephrectomy)
DOI
10.1016/j.urolonc.2022.08.013
PMID
36441070
发布时间
2024-03-15
基金项目
T32 CA247815/CA/NCI NIH HHS/United States
- 浏览0
Urologic oncology
51.e25-51.e31页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



